한글목차

의료기기 RA(Regulatory Affairs) 시장 규모는 2025년 79억 8,000만 달러에서 2034년에는 190억 9,000만 달러에 이를 것으로 예측되며, 2026-2034년 CAGR 10.18%를 나타낼 전망입니다.

의료기기 규제 이슈 시장은 의료 환경이 점점 더 복잡해지고 서로 밀접하게 연관되어 있는 가운데, 큰 변화의 기운이 고조되고 있습니다. 인공지능, 머신러닝과 같은 첨단 기술의 등장으로 의료기기가 엄격한 안전성과 유효성 기준을 충족하도록 규제 프레임워크가 변화하고 있습니다. 디지털 헬스 솔루션의 통합을 위해서는 환자의 복지를 보호하면서 혁신을 촉진할 수 있는 강력한 규제 접근법이 필수적입니다. 세계 보건 이슈가 심각해짐에 따라 규제 관련 전문 지식에 대한 수요가 급증하고, 조직은 전문 인력과 고도의 컴플라이언스 전략에 투자해야할 것입니다.

또한, 의료기기 시장의 세계화에 따라 각 국가 간 조화로운 규제 관행의 필요성이 높아지고 있습니다. 각국이 승인 프로세스의 효율성을 높이기 위해 노력하는 가운데, 규제 업무 전문가는 국제 규제의 복잡성을 극복하는 데 있어 매우 중요한 역할을 담당합니다. 이러한 추세는 원격의료와 원격 환자 모니터링의 보급 확대에 따라 더욱 가속화되고 있으며, 혁신적인 솔루션에 대한 신속한 접근을 보장하기 위해 민첩한 규제 대응이 요구되고 있습니다. 이 시장 전망은 제조업체, 규제 기관, 의료 서비스 제공업체 등 이해관계자들이 협력하여 혁신을 촉진할 수 있는 환경을 조성하는 협력적 접근 방식으로 특징지어질 것입니다.

또한, 개인 맞춤형 의료의 부상과 환자 중심 접근에 대한 강조가 증가하면서 규제 환경이 재편되고 있습니다. 의료기기가 개인의 요구에 더욱 적합해짐에 따라, 규제 프레임워크도 이러한 발전에 대응할 수 있도록 진화해야 합니다. 이러한 변화에는 실제 데이터(RWE)와 시판 후 조사(PMS)에 대한 더 깊은 이해가 필요하며, 이는 기기가 초기 승인 기준을 충족할 뿐만 아니라 다양한 환자군에서도 효과적으로 작동할 수 있도록 보장하기 위한 것입니다. 의료기기 규제 관련 시장은 기술 발전, 세계화, 환자 결과 개선에 대한 노력에 힘입어 혁신적 성장의 기로에 서 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 의료기기 RA(Regulatory Affairs) 시장 : 서비스별

제5장 세계의 의료기기 RA(Regulatory Affairs) 시장 : 유형별

제6장 세계의 의료기기 RA(Regulatory Affairs) 시장 : 서비스 제공업체별

제7장 세계의 의료기기 RA(Regulatory Affairs) 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Medical Device Regulatory Affairs Market size is expected to reach USD 19.09 Billion in 2034 from USD 7.98 Billion (2025) growing at a CAGR of 10.18% during 2026-2034.

The Medical Device Regulatory Affairs market is poised for significant evolution as the healthcare landscape becomes increasingly complex and interconnected. With the advent of advanced technologies such as artificial intelligence and machine learning, regulatory frameworks are adapting to ensure that medical devices meet stringent safety and efficacy standards. The integration of digital health solutions necessitates a robust regulatory approach, fostering innovation while safeguarding patient welfare. As global health challenges intensify, the demand for regulatory expertise will surge, compelling organizations to invest in specialized talent and advanced compliance strategies.

Moreover, the globalization of the medical device market is driving the need for harmonized regulatory practices across jurisdictions. As countries strive to streamline their approval processes, regulatory affairs professionals will play a pivotal role in navigating the intricacies of international regulations. This trend is further amplified by the increasing prevalence of telemedicine and remote patient monitoring, which require agile regulatory responses to ensure timely access to innovative solutions. The future of this market will be characterized by a collaborative approach, where stakeholders-including manufacturers, regulatory bodies, and healthcare providers-work in tandem to foster a conducive environment for innovation.

In addition, the rise of personalized medicine and the growing emphasis on patient-centric approaches are reshaping the regulatory landscape. As medical devices become more tailored to individual needs, regulatory frameworks must evolve to accommodate these advancements. This shift will necessitate a deeper understanding of real-world evidence and post-market surveillance, ensuring that devices not only meet initial approval criteria but also continue to perform effectively in diverse patient populations. The Medical Device Regulatory Affairs market is thus on the brink of transformative growth, driven by technological advancements, globalization, and a commitment to enhancing patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Regulatory Consulting
• Legal Representation
• Regulatory Writing & Publishing
• Product Registration & Clinical Trial Applications
• Other Services

By Type

• Diagnostic
• Therapeutic

By Service Provider

• In-house
• Outsource

COMPANIES PROFILED

• ICON Plc, Emergo, Freyr, Laboratory Corporation of America Holdings, IQVIA Inc, Intertek Group plc, SGS Socit Gnrale de Surveillance SA, Promedica International, Integer Holdings Corporation, Medpace

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET: BY SERVICE 2022-2034 (USD MN and K Units)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Regulatory Consulting Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.3. Legal Representation Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.4. Regulatory Writing & Publishing Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.5. Product Registration & Clinical Trial Applications Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.6. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET: BY TYPE 2022-2034 (USD MN and K Units)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Diagnostic Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET: BY SERVICE PROVIDER 2022-2034 (USD MN and K Units)

• 6.1. Market Analysis, Insights and Forecast Service Provider
• 6.2. In-house Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.3. Outsource Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET: BY REGION 2022-2034(USD MN and K Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.2.1 By Service
  • 7.2.2 By Type
  • 7.2.3 By Service Provider
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.3.1 By Service
  • 7.3.2 By Type
  • 7.3.3 By Service Provider
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.4.1 By Service
  • 7.4.2 By Type
  • 7.4.3 By Service Provider
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.5.1 By Service
  • 7.5.2 By Type
  • 7.5.3 By Service Provider
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.6.1 By Service
  • 7.6.2 By Type
  • 7.6.3 By Service Provider
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 ICON Plc
  • 9.2.2 Emergo
  • 9.2.3 Freyr
  • 9.2.4 Laboratory Corporation Of America Holdings
  • 9.2.5 IQVIA Inc
  • 9.2.6 Intertek Group Plc
  • 9.2.7 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 9.2.8 Promedica International
  • 9.2.9 Integer Holdings Corporation
  • 9.2.10 Medpace